AAAAAA
Results:
1-14
|
Results: 14
Authors:
SIMONS ER
MARSHALL DCL
LONG HJ
OTTO K
BILLINGSLEA A
TIBBLES H
WELLS J
EISENHAUER P
FINE RE
CRIBBS DH
DAVIES TA
ABRAHAM CR
Citation: Er. Simons et al., BLOOD-BRAIN-BARRIER ENDOTHELIAL-CELLS EXPRESS CANDIDATE AMYLOID PRECURSOR PROTEIN-CLEAVING SECRETASES, Amyloid (Carnforth), 5(3), 1998, pp. 153-162
Authors:
DAVIES TA
BILLINGSLEA AM
LONG HJ
TIBBLES H
WELLS JM
EISENHAUER PB
SMITH SJ
CRIBBS DH
FINE RE
SIMONS ER
Citation: Ta. Davies et al., BRAIN ENDOTHELIAL-CELL ENZYMES CLEAVE PLATELET-RETAINED AMYLOID PRECURSOR PROTEIN, The Journal of laboratory and clinical medicine, 132(4), 1998, pp. 341-350
CAN MOLGRAMOSTIM ENHANCE THE ANTITUMOR EFFECTS OF CYTOTOXIC DRUGS IN PATIENTS WITH ADVANCED SARCOMAS
Authors:
EDMONSON JH
LONG HJ
KVOLS LK
MANN BS
GRILL JP
Citation: Jh. Edmonson et al., CAN MOLGRAMOSTIM ENHANCE THE ANTITUMOR EFFECTS OF CYTOTOXIC DRUGS IN PATIENTS WITH ADVANCED SARCOMAS, Annals of oncology, 8(7), 1997, pp. 637-641
Authors:
DAVIES TA
LONG HJ
SGRO K
RATHBUN WH
MCMENAMIN ME
SEETOO K
TIBBLES H
BILLINGSLEA AM
FINE RE
FISHMAN JB
LEVESQUE CA
SMITH SJ
WELLS JM
SIMONS ER
Citation: Ta. Davies et al., ACTIVATED ALZHEIMER-DISEASE PLATELETS RETAIN MORE BETA-AMYLOID PRECURSOR PROTEIN, Neurobiology of aging, 18(2), 1997, pp. 147-153
Authors:
DAVIES TA
LONG HJ
TIBBLES HE
SGRO KR
WELLS JM
RATHBUN WH
SEETOO KF
MCMENAMIN ME
SMITH SJ
FELDMAN RG
LEVESQUE CA
FINE RE
SIMONS ER
Citation: Ta. Davies et al., MODERATE AND ADVANCED ALZHEIMERS PATIENTS EXHIBIT PLATELET ACTIVATIONDIFFERENCES, Neurobiology of aging, 18(2), 1997, pp. 155-162
Authors:
DAVIES TA
LONG HJ
RATHBUN WH
SGRO KR
TIBBLES H
SMITH SJ
SEETOO KF
MCMENAMIN ME
JOHNSON R
WELLS JM
LEVESQUE C
FINE RE
SIMONS ER
Citation: Ta. Davies et al., PLATELETS FROM PATIENTS WITH ALZHEIMERS-DISEASE OR OTHER DEMENTIAS EXHIBIT DISEASE-SPECIFIC AND APOLIPOPROTEIN-E CORRELATABLE DEFECTS, AMYLOID-INTERNATIONAL JOURNAL OF EXPERIMENTAL AND CLINICAL INVESTIGATION, 3(1), 1996, pp. 13-19
Authors:
LONG HJ
Citation: Hj. Long, NEOADJUVANT CHEMOTHERAPY IN CERVIX CANCER - IS IT EFFECTIVE, Journal of clinical oncology, 13(8), 1995, pp. 2141-2141
Authors:
LONG HJ
LANGDON RM
CHA SS
VEEDER MH
PFEIFLE DM
KROOK JE
EBBERT LP
TSCHETTER LK
ROSHON SG
Citation: Hj. Long et al., PHASE-II TRIAL OF METHOTREXATE, VINBLASTINE, DOXORUBICIN, AND CISPLATIN IN ADVANCED RECURRENT ENDOMETRIAL CARCINOMA, Gynecologic oncology, 58(2), 1995, pp. 240-243
Authors:
LONG HJ
CROSS WG
WIEAND HS
WEBB MJ
MAILLIARD JA
KUGLER JW
TSCHETTER LK
KARDINAL CG
EBBERT LP
RAYSON S
Citation: Hj. Long et al., PHASE-II TRIAL OF METHOTREXATE, VINBLASTINE, DOXORUBICIN, AND CISPLATIN IN ADVANCED RECURRENT CARCINOMA OF THE UTERINE CERVIX AND VAGINA, Gynecologic oncology, 57(2), 1995, pp. 235-239
Authors:
EDMONSON JH
LONG HJ
KVOLS LK
Citation: Jh. Edmonson et al., CYTOTOXIC DRUGS PLUS SUBCUTANEOUS GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR - CAN MOLGRAMOSTIM ENHANCE ANTISARCOMA THERAPY, Journal of the National Cancer Institute, 86(4), 1994, pp. 312-314
Authors:
LONG HJ
NELIMARK RA
SU JQ
GARNEAU SC
LEVITT R
GOLDBERG RM
POON MA
KUGLER JW
Citation: Hj. Long et al., PHASE-II EVALUATION OF 5-FLUOROURACIL AND LOW-DOSE LEUCOVORIN IN CISPLATIN-REFRACTORY ADVANCED OVARIAN-CARCINOMA, Gynecologic oncology, 54(2), 1994, pp. 180-183
Authors:
LONG HJ
Citation: Hj. Long, SUBSPECIALTY CLINICS - ONCOLOGY PACLITAXEL (TAXOL) - A NOVEL ANTICANCER CHEMOTHERAPEUTIC DRUG, Mayo Clinic proceedings, 69(4), 1994, pp. 341-345
Authors:
LEE TC
HOOK CC
LONG HJ
Citation: Tc. Lee et al., SEVERE EXFOLIATIVE DERMATITIS ASSOCIATED WITH HAND ISCHEMIA DURING CISPLATIN THERAPY, Mayo Clinic proceedings, 69(1), 1994, pp. 80-82
Authors:
INGLE JN
KUROSS SA
MAILLIARD JA
LOPRINZI CL
JUNG SH
NELIMARK RA
KROOK JE
LONG HJ
Citation: Jn. Ingle et al., EVALUATION OF PIROXANTRONE IN WOMEN WITH METASTATIC BREAST-CANCER ANDFAILURE ON NONANTHRACYCLINE CHEMOTHERAPY, Cancer, 74(6), 1994, pp. 1733-1738
Risultati:
1-14
|